为耐火OHCA进行体外心肺复苏:来自三项随机对照试验的经验教训 - - 试验人员的观点
Johannes F H Ubben1,2, Samuel Heuts3,4, Thijs S R Delnoij1,5
1Department of Intensive Care Medicine, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
European heart journal. Acute cardiovascular care
|July 22, 2023
概括
身体外心肺复苏 (ECPR) 显示出对医院外心脏骤停的有希望. 虽然最近的试验结果各不相同,但ECPR的成功取决于严格的患者选择和针对耐火病例的专用计划.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 关键的护理关键的护理
背景情况:
- 耐火性医院外心脏骤停 (OHCA) 带来了重大治疗挑战.
- 身体外心肺复苏 (ECPR) 已经成为OHCA的潜在先进干预措施.
- 之前关于OHCAECPR的证据是基于观察性研究和有限的试验.
研究的目的:
- 综合和批判性地评估最近关于OHCAECPR的随机对照试验 (RCT) 的证据.
- 为了协调ARREST试验,布拉格OHCA研究和INCEPTION试验中看似不同的结果.
- 为OHCA提供关于最佳实施ECPR计划的指导.
主要方法:
- 对三项最近的RCT进行了审查和元分析:ARREST,布拉格OHCA研究和INCEPTION试验.
- 对研究设计,患者选择标准和结果措施的比较分析.
- 评估ECPR对OHCA患者的生存和神经功能的影响.
主要成果:
- 这三个RCT虽然产生了看似不同的结果,但为OHCA提供了对ECPR的补充证据.
- 使用ECPR的高成功率是可以实现的,但需要严格的患者选择和高度专注的方法.
- 务实,不那么选择性地实施ECPR并不能持续地改善耐火OHCA的结果.
结论:
- 在最近的试验中,OHCA的ECPR并不是本质上矛盾的;它的有效性取决于上下文.
- 成功的ECPR计划要求严格遵守先决条件,包括严格的选择标准和专门的资源.
- 为OHCA考虑或执行ECPR的医疗保健中心必须批判性地评估其满足这些基本要求以获得最佳患者结果的能力.
更多相关视频
相关概念视频
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
01:23Cardiopulmonary Resuscitation III: AED Use
39
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
39
01:21Cardiopulmonary Resuscitation I: Adult
21
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
21
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:30Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16